Company Filing History:
Years Active: 2018
Title: Maryline Boyer: Innovator in Opioid Formulation
Introduction
Maryline Boyer is a notable inventor based in Louveciennes, France. She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of opioid medications. Her innovative work aims to improve patient outcomes by addressing critical issues related to opioid administration.
Latest Patents
Maryline Boyer holds 1 patent for her invention titled "Reduction of opioid blood fluctuations." This patent relates to the use of a sustained release matrix containing at least one opioid for producing a solid oral formulation in tablet form. The formulation is designed to reduce blood concentration fluctuations of the opioid, thereby enhancing its therapeutic efficacy and safety.
Career Highlights
Throughout her career, Maryline has demonstrated a strong commitment to advancing pharmaceutical science. Her work has been instrumental in developing formulations that improve the management of pain while minimizing the risks associated with opioid use. She is currently associated with Ethypharm, Inc., a company known for its focus on innovative drug delivery systems.
Collaborations
Maryline has collaborated with several talented professionals in her field, including Catherine Herry and Francoise Vauzelle-Kervroedan. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in pharmaceutical technology.
Conclusion
Maryline Boyer's contributions to opioid formulation represent a significant advancement in the pharmaceutical industry. Her innovative approach to reducing blood fluctuations in opioid administration showcases her dedication to improving patient care.